ONTARIO, Calif.--(BUSINESS WIRE)--Medegen, a leading innovator in infusion therapy medical products, announced today that it is pursuing an appeal in the United States Court of Appeals for the Federal Circuit in Washington, D.C., of a judgment of patent non-infringement entered in favor of ICU Medical Inc. (NASDAQ: ICUI) by a district court judge in the Central District of California.
